American Society of Hirudotherapy

Glaucoma (Adjunctive)

Investigational adjunctive use in primary open-angle glaucoma; weak case-series evidence. Not a substitute for IOP-lowering eye drops or surgery.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for glaucoma. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for glaucoma is investigational and not endorsed by ophthalmology guideline bodies.
What evidence exists?
Tier C (investigational). Small uncontrolled studies were identified, most of them Russian; in one Russian thesis of 90 patients with early open-angle glaucoma already on treatment, eye pressure fell by less than 2 mmHg and was back to baseline by nine months. A Russian medical book also retells older clinical reports without a clearly described comparison group (see “What the books describe” below). There are no randomized controlled trials. Glaucoma is a sight-threatening, progressive optic neuropathy — evidence-based first-line therapy is prostaglandin analogs, beta-blockers, selective laser trabeculoplasty (SLT), or trabeculectomy. Leech therapy is NOT a substitute, and undertreated glaucoma causes irreversible blindness.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after detachment (peri-orbital location)
  • Bruising around the temple and behind the ear for 5 to 10 days
  • Itching and irritation near sensitive periocular skin
  • Local skin infection or, rarely, Aeromonas infection
  • Catastrophic harm if leech is mistakenly applied to the eyelid, conjunctiva, or orbit (NEVER do this)
  • Allergic reaction to leech saliva (uncommon)
  • Delayed presentation to ophthalmology if used as substitute for evidence-based care, leading to irreversible vision loss
  • Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
Who should not consider this
  • Patients on blood thinners (anticoagulants such as warfarin, DOACs or heparin)
  • Patients with hemophilia or other bleeding disorders
  • Patients with anemia
  • Patients with acute angle-closure glaucoma (ophthalmologic emergency)
  • Patients whose IOP is not yet controlled by prescribed therapy
  • Patients considering this INSTEAD OF prescribed glaucoma drops or surgery
  • Patients with recent ocular surgery or active ocular infection
What to ask your clinician
  • Will I continue all prescribed glaucoma medications and ophthalmology follow-up?
  • What evidence supports leech therapy for glaucoma specifically, and what is the realistic IOP-lowering effect?
  • How will leeches be kept off the eyelid, conjunctiva, and orbit?
  • What is the practitioner's experience treating glaucoma with leech therapy?
  • How will IOP be monitored before and after sessions?
  • What is the cost, and is it covered by insurance? (typically not)
  • What red flags require me to seek urgent ophthalmologic care?
When to seek urgent care
  • Sudden severe eye pain, eye redness, halos around lights, nausea/vomiting (possible acute angle-closure — go to ER)
  • Sudden vision loss, new floaters or flashes, or curtain across vision
  • Bleeding from a bite site lasting more than 24 to 48 hours
  • Spreading redness or pus near the eye (orbital cellulitis is sight- and life-threatening)
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty

What this does NOT mean

  • This is not FDA-cleared for glaucoma.
  • The small uncontrolled studies identified do NOT establish that leech therapy lowers IOP meaningfully or durably.
  • Glaucoma causes irreversible blindness if undertreated — leech therapy is NOT a substitute for prescribed drops, SLT, or surgery.
  • Mechanism rationale (episcleral venous drainage) does NOT establish clinical efficacy.
  • Leech therapy must NEVER be applied near the eyelid or orbit; periocular placement carries cosmetic risk.

Clinical Profile

Category
Ophthalmologic
ICD-10
H40.10, H40.11, H40.20
Safety tier
High

Evidence Summary

No randomized trial of leech therapy for glaucoma was identified. Small uncontrolled clinical series have measured intraocular pressure: a Russian candidate thesis (Beletskaya 2007; 90 patients with early open-angle glaucoma already controlled by drops or surgery) found a mean true IOP of 19.2 mmHg before, 18.5 right after leeches, 17.6 at 3 months, 18.1 at 6 months and 19.7 at 9 months, and an open-label conference abstract (Janardhanan 2016; 30 patients with IOP above 25 mmHg) reported an average fall of about 5 mmHg after one month. The 2004 Baskova and Isakhanyan monograph additionally describes Soviet and Russian series, including Bagdasarova 1973 (181 glaucoma patients, tonometry before and after leech application) and Mozherenkov 1998 (302 acute glaucoma attacks, 177 given leeches in addition to drugs; attack resolved in 87% versus 77%). The proposed mechanism (improved episcleral venous drainage) is speculative. Ophthalmology consensus does NOT endorse leech therapy as glaucoma treatment, and it is not a substitute for prostaglandin analogs, beta-blockers, selective laser trabeculoplasty, or trabeculectomy. ASH position: not recommended outside research protocols; use is investigational.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Baskova and Isakhanyan write that in the eye clinic hirudotherapy finds its greatest use in inflammatory eye diseases, glaucoma and vascular pathology of the organ of vision, and in the list of indications they name an acute attack of glaucoma[B1].
  • They retell the work of Bagdasarova (1973) in 181 patients: she studied the effect of leeches on the pressure in the eye and on the exchange of the fluid inside the eye in glaucoma; according to the description, the pressure was already falling after an hour and approached its starting level after 24 hours; the retelling says nothing about observation beyond a day[B1].
  • On the acute attack of glaucoma, the opinions the book cites diverged: Kartasheva (1979) doubted whether leeches should be included in the treatment of the attack, because it is hard to know in advance whether the method will stop the attack within a day; later, according to Semikova (1993) and Mozherenkov and colleagues (1998), the use of leeches in an acute attack was judged advisable[B1].
  • In the works described by the authors, an acute attack of glaucoma is an emergency situation: in the work of Bondareva and Zhitenev (500 patients) leeches were prescribed as one element of emergency care alongside taking Diacarb and repeated pilocarpine drops, and in Mozherenkov and colleagues — in addition to pressure-lowering drugs, eye drops and other treatment, but not instead of them[B1].
  • According to Mozherenkov and colleagues (1998), of 302 patients with an acute attack, 177 received leeches in addition to medications; according to their report, the attack was stopped in most cases, but with which group the result was compared is not clear from what is printed in the book, and how the patients were assigned to groups is not stated[B1].
  • For outpatient practice the authors cite the work of Chaban and Savinov (1995), in which hirudotherapy was used in glaucoma, among other eye diseases, as a method supplementing standard treatment[B1].
  • Among the contraindications listed in the book by Baskova and Isakhanyan (their list is longer) are hemophilia, hemorrhagic diatheses, anemias and the simultaneous use of anticoagulants; Michalsen et al. (chapter 8, “Contraindications,” Flecken and Michalsen) call hemophilia and the use of anticoagulants an absolute contraindication, and in anemia, in their words, treatment involving blood loss is generally contraindicated[B1][B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Acute angle-closure glaucoma (emergency)
  • Recent (<3 months) eye surgery
  • Active uveitis or scleritis

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.